Advertisement
Research Article|Articles in Press

Elabela-APJ axis mediates angiogenesis via YAP/TAZ pathway in cerebral ischemia/reperfusion injury

  • Wenyu Li
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Pengfei Xu
    Correspondence
    Reprint requests: Pengfei Xu, Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Lingqi Kong
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Shuo Feng
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Nan Shen
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Hongmei Huang
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Wuxuan Wang
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Xiang Xu
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Xinyue Wang
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Guoping Wang
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Yan Zhang
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Wen Sun
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Wei Hu
    Correspondence
    Reprint requests: Pengfei Xu, Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
  • Xinfeng Liu
    Correspondence
    Reprint requests: Pengfei Xu, Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China
    Affiliations
    Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
    Search for articles by this author
Published:February 20, 2023DOI:https://doi.org/10.1016/j.trsl.2023.02.002

      ABSTRACT

      Angiogenesis helps to improve neurological recovery by repairing damaged brain tissue and restoring cerebral blood flow (CBF). The role of the Elabela (ELA)-Apelin receptor (APJ) system in angiogenesis has gained much attention. We aimed to investigate the function of endothelial ELA on postischemic cerebral angiogenesis. Here, we demonstrated that the endothelial ELA expression was upregulated in the ischemic brain and treatment with ELA-32 mitigated brain injury and enhanced the restoration of CBF and newly formed functional vessels following cerebral ischemia/reperfusion (I/R) injury. Furthermore, ELA-32 incubation potentiated proliferation, migration, and tube formation abilities of the mouse brain endothelial cells (bEnd.3 cells) under oxygen-glucose deprivation/reoxygenation (OGD/R) condition. RNA sequencing analysis indicated that ELA-32 incubation had a role in the Hippo signaling pathway, and improved angiogenesis-related gene expression in OGD/R-exposed bEnd.3 cells. Mechanistically, we depicted that ELA could bind to APJ and subsequently activate YAP/TAZ signaling pathway. Silence of APJ or pharmacological blockade of YAP abolished the pro-angiogenesis effects of ELA-32. Together, these findings highlight the ELA-APJ axis as a potential therapeutic strategy for ischemic stroke by showing how activation of this pathway promotes poststroke angiogenesis.

      Keywords

      Abbreviations:

      ACA (Anterior cerebral artery), AIS (Acute ischemic stroke), ANG2 (Angiopoietin 2), APJ (Apelin receptor), CBF (Cerebral blood flow), CCA (Common carotid artery), CTGF (Connective tissue growth factor), CYR61 (Cysteine-rich 61), ECA (External carotid artery), ECs (Endothelial cells), ELA (Elabela), HUVECs (Human umbilical vein endothelial cells), I/R (Ischemia/Reperfusion), ICA (Internal carotid artery), MCA (Middle cerebral artery), MCAO (Middle cerebral artery occlusion), mNSS (Modified Neurological severity scoring), NOR (Novel object recognition), OGD/R (Oxygen-glucose deprivation/reoxygenation), PCA (Posterior cerebral artery), p-YAP (Phosphorylated-YAP), TAZ (Transcriptional co-activator with PDZ-binding motif), TEAD (Transcriptional enhancer associate domain), VSMCs (Vascular smooth muscle cells), YAP (Yes-associated protein)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Campbell BCV
        • De Silva DA
        • Macleod MR
        • et al.
        Ischaemic stroke.
        Nat Rev Dis Primers. 2019; 5: 70
        • Arenillas JF
        • Sobrino T
        • Castillo J
        • et al.
        The role of angiogenesis in damage and recovery from ischemic stroke.
        Curr Treat Options Cardiovasc Med. 2007; 9: 205-212
        • Shuaib A
        • Butcher K
        • Mohammad AA
        • et al.
        Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target.
        Lancet Neurol. 2011; 10: 909-921
        • Sun P
        • Ma F
        • Xu Y
        • et al.
        Genetic deletion of endothelial microRNA-15a/16-1 promotes cerebral angiogenesis and neurological recovery in ischemic stroke through Src signaling pathway.
        J Cereb Blood Flow Metab. 2021; 41: 2725-2742
        • George PM
        • Steinberg GK
        Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments.
        Neuron. 2015; 87: 297-309
        • Heil M
        • Eitenmuller I
        • Schmitz-Rixen T
        • et al.
        Arteriogenesis versus angiogenesis: similarities and differences.
        J Cell Mol Med. 2006; 10: 45-55
        • Hatakeyama M
        • Ninomiya I
        • Kanazawa M
        Angiogenesis and neuronal remodeling after ischemic stroke.
        Neural Regen Res. 2020; 15: 16-19
        • Krupinski J
        • Kaluza J
        • Kumar P
        • et al.
        Role of angiogenesis in patients with cerebral ischemic stroke.
        Stroke. 1994; 25: 1794-1798
        • Beck H
        • Plate KH
        Angiogenesis after cerebral ischemia.
        Acta Neuropathol. 2009; 117: 481-496
        • Zhang Y
        • Wang Y
        • Lou Y
        • et al.
        Elabela, a newly discovered APJ ligand: similarities and differences with apelin.
        Peptides. 2018; 109: 23-32
        • Yang P
        • Read C
        • Kuc RE
        • et al.
        Elabela/toddler is an endogenous agonist of the apelin apj receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension.
        Circulation. 2017; 135: 1160-1173
        • Zhou S
        • Wang J
        • Wang Q
        • et al.
        Essential role of the elabela-apj signaling pathway in cardiovascular system development and diseases.
        J Cardiovasc Pharmacol. 2020; 75: 284-291
        • Jin L
        • Pan Y
        • Li Q
        • et al.
        Elabela gene therapy promotes angiogenesis after myocardial infarction.
        J Cell Mol Med. 2021; 25: 8537-8545
        • Chen X
        • Zhou C
        • Xu D
        • et al.
        Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment.
        Stem Cell Res Ther. 2022; 13: 32
        • Wang Z
        • Yu D
        • Wang M
        • et al.
        Elabela-apelin receptor signaling pathway is functional in mammalian systems.
        Sci Rep. 2015; 5: 8170
        • Yu FX
        • Zhao B
        • Panupinthu N
        • et al.
        Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
        Cell. 2012; 150: 780-791
        • Azad T
        • Ghahremani M
        • Yang X
        The role of YAP and TAZ in angiogenesis and vascular mimicry.
        Cells. 2019; 8
        • Ma C
        • Peng P
        • Zhou Y
        • et al.
        MicroRNA93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionomega.
        Mol Med Rep. 2020; 22: 483-493
        • Zheng Z
        • Li C
        • Shao G
        • et al.
        Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI.
        Cell Death Dis. 2021; 12: 754
        • Zhu M
        • Liu X
        • Wang Y
        • et al.
        YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells.
        Exp Cell Res. 2018; 373: 155-163
        • Xu P
        • Zhang X
        • Liu Q
        • et al.
        Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke.
        Cell Death Dis. 2019; 10: 555
        • Xu P
        • Tao C
        • Zhu Y
        • et al.
        TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage.
        J Neuroinflammation. 2021; 18: 188
        • Wang X
        • Freire Valls A
        • Schermann G
        • et al.
        YAP/TAZ orchestrate VEGF signaling during developmental angiogenesis.
        Dev Cell. 2017; 42: 462-478e7
        • Murakami M
        • Nakagawa M
        • Olson EN
        • et al.
        A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.
        Proc Natl Acad Sci U S A. 2005; 102: 18034-18039
        • Xu P
        • Liu Q
        • Xie Y
        • et al.
        Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia/reperfusion injury through NRF2-mediated antioxidant pathway.
        Redox Biol. 2018; 18: 158-172
        • Okyere B
        • Mills 3rd, WA
        • Wang X
        • et al.
        EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke.
        J Clin Invest. 2020; 130: 1024-1035
        • Defazio RA
        • Levy S
        • Morales CL
        • et al.
        A protocol for characterizing the impact of collateral flow after distal middle cerebral artery occlusion.
        Transl Stroke Res. 2011; 2: 112-127
        • Chng SC
        • Ho L
        • Tian J
        • et al.
        ELABELA: a hormone essential for heart development signals via the apelin receptor.
        Dev Cell. 2013; 27: 672-680
        • Peng W
        • Wan L
        • Luo Z
        • et al.
        Microglia-derived exosomes improve spinal cord functional recovery after injury via inhibiting oxidative stress and promoting the survival and function of endothelia cells.
        Oxid Med Cell Longev. 2021; 20211695087
        • Sun P
        • Zhang K
        • Hassan SH
        • et al.
        Endothelium-targeted deletion of microrna-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery.
        Circ Res. 2020; 126: 1040-1057
        • Boopathy GTK
        • Hong W
        Role of hippo pathway-YAP/TAZ signaling in angiogenesis.
        Front Cell Dev Biol. 2019; 7: 49
        • Read C
        • Nyimanu D
        • Williams TL
        • et al.
        International union of basic and clinical pharmacology. CVII. structure and pharmacology of the apelin receptor with a recommendation that Elabela/toddler is a second endogenous peptide ligand.
        Pharmacol Rev. 2019; 71: 467-502
        • Xi Y
        • Yu D
        • Yang R
        • et al.
        Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats.
        Int J Cardiol. 2019; 292: 180-187
        • Zhou Q
        • Zhang K
        • Guo Y
        • et al.
        Elabela-APJ axis contributes to embryonic development and prevents pre-eclampsia in pregnancy.
        Acta Biochim Biophys Sin (Shanghai). 2018; 50: 319-321
        • Liu W
        • Yan J
        • Pan W
        • et al.
        Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.
        Ann Transl Med. 2020; 8: 243
        • Chen H
        • Wang L
        • Wang W
        • et al.
        ELABELA and an ELABELA fragment protect against AKI.
        J Am Soc Nephrol. 2017; 28: 2694-2707
        • Devic E
        • Rizzoti K
        • Bodin S
        • et al.
        Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ.
        Mech Dev. 1999; 84: 199-203
        • Perjes A
        • Kilpio T
        • Ulvila J
        • et al.
        Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart.
        Basic Res Cardiol. 2016; 111: 2
        • Yang Y
        • Lv SY
        • Ye W
        • et al.
        Apelin/APJ system and cancer.
        Clin Chim Acta. 2016; 457: 112-116
        • Chen Z
        • Wu C
        • Liu Y
        • et al.
        ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
        Cell Death Dis. 2020; 11: 698
        • Zhang Z
        • Tang J
        • Song J
        • et al.
        Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling.
        Free Radic Biol Med. 2022; 181: 130-142
        • Ma J
        • Hu H
        • Lin M
        • et al.
        ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis.
        Placenta. 2021; 106: 30-39
        • Ma Z
        • Song JJ
        • Martin S
        • et al.
        The Elabela-APJ axis: a promising therapeutic target for heart failure.
        Heart Fail Rev. 2021; 26: 1249-1258
        • Arai K
        • Jin G
        • Navaratna D
        • et al.
        Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke.
        FEBS J. 2009; 276: 4644-4652
        • Khamchai S
        • Chumboatong W
        • Hata J
        • et al.
        Morin attenuated cerebral ischemia/reperfusion injury through promoting angiogenesis mediated by angiopoietin-1-Tie-2 Axis and wnt/beta-catenin pathway.
        Neurotox Res. 2022; 40: 14-25
        • Font MA
        • Arboix A
        • Krupinski J
        Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke.
        Curr Cardiol Rev. 2010; 6: 238-244
        • Ribo M
        • Flores A
        • Rubiera M
        • et al.
        Extending the time window for endovascular procedures according to collateral pial circulation.
        Stroke. 2011; 42: 3465-3469
        • Ho L
        • van Dijk M
        • Chye STJ
        • et al.
        ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice.
        Science. 2017; 357: 707-713
        • Liu J
        • Wang Y
        • Akamatsu Y
        • et al.
        Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.
        Prog Neurobiol. 2014; 115: 138-156
        • Okyere B
        • Creasey M
        • Lebovitz Y
        • et al.
        Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.
        J Neurosci Methods. 2018; 293: 86-96
        • Li Y
        • Choi WJ
        • Qin W
        • et al.
        Optical coherence tomography based microangiography provides an ability to longitudinally image arteriogenesis in vivo.
        J Neurosci Methods. 2016; 274: 164-171
        • Xu T
        • Jia J
        • Xu N
        • et al.
        Apelin receptor upregulation in spontaneously hypertensive rat contributes to the enhanced vascular smooth muscle cell proliferation by activating autophagy.
        Ann Transl Med. 2021; 9: 627
        • Hashimoto T
        • Kihara M
        • Imai N
        • et al.
        Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.
        Am J Pathol. 2007; 171: 1705-1712
        • Shen Y
        • Wang X
        • Liu Y
        • et al.
        STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis.
        Sci Signal. 2021; 14: eabj8393
        • Fan M
        • Yang K
        • Wang X
        • et al.
        Endothelial cell HSPA12B and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction.
        JCI Insight. 2020; 5
        • Moon S
        • Lee S
        • Caesar JA
        • et al.
        A CTGF-YAP regulatory pathway is essential for angiogenesis and barriergenesis in the retina.
        iScience. 2020; 23101184
        • Santucci M
        • Vignudelli T
        • Ferrari S
        • et al.
        The hippo pathway and yap/taz-tead protein-protein interaction as targets for regenerative medicine and cancer treatment.
        J Med Chem. 2015; 58: 4857-4873
        • Crawford JJ
        • Bronner SM
        • Zbieg JR
        Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
        Expert Opin Ther Pat. 2018; 28: 867-873